Methylamine

Methylamine

SCHEMBL27801352

CN.CN.CN.[c]1cccc(-c2cn[nH]c2)c1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AKT2 P31751 7/20 0.53
AKT1 P31749 1/20 0.53
ILK Q13418 1/20 0.37
MAPK1 P28482 1/20 0.36
PIM1 P11309 2/20 0.36
ROCK2 O75116 2/20 0.36
PIM3 Q86V86 1/20 0.36
PIM2 Q9P1W9 1/20 0.36
CHEK1 O14757 3/20 0.35
CHEK2 O96017 1/20 0.35
PLK1 P53350 1/20 0.35
CLK2 P49760 1/20 0.35
HIPK1 Q86Z02 1/20 0.35
DYRK2 Q92630 1/20 0.35
HIPK2 Q9H2X6 1/20 0.35
HIPK3 Q9H422 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
LRRK2 Q5S007 1/20 0.34
MAPK8 P45983 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL294336 0.95 AKT2 (0.59) AKT2AKT1ILKMAPK1PIM1
SCHEMBL610112 0.72 ALDH1A1 (0.33)
SCHEMBL1570014 0.71 FTO (0.42)
SCHEMBL197153 0.71 AKT2 (0.61) AKT2AKT1ILKMAPK1PIM1
SCHEMBL82741 0.71 AKT2 (1.00) AKT2AKT1ILKPIM1ROCK2
Benzene SCHEMBL28198087 0.71 AKT2 (1.00) AKT2AKT1ILKPIM1ROCK2
SCHEMBL29253578 0.70 AKT1 (0.41) AKT2AKT1PIM1ROCK2PIM3
SCHEMBL3740850 0.69 AKT2 (0.70) AKT2AKT1ILKMAPK1PIM1
SCHEMBL3598468 0.69 METAP2 (0.62)
SCHEMBL30424015 0.69 AKT2 (0.71) AKT2AKT1ILKPIM1ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102123991-A 2-arylaminoquinazolines for the treatment of proliferative diseases NOVARTIS AG 2011-07-13 CN disclosed
CN-101652352-A Quinazolines for PDK1 inhibition NOVARTIS VACCINES & DIAGNOSTIC 2010-02-17 CN disclosed